Recombinant Human TAP1, N-His

Reference: ARO-P12869
Size

100ug

Brand

Arovia

Product type

Recombinant Proteins

Product nameRecombinant Human TAP1, N-His
Origin speciesHuman
Expression systemProkaryotic expression
Molecular weight33.24 kDa
BufferLyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
FormLiquid
Delivery conditionDry Ice
Delivery lead time in business days3-5 days if in stock; 3-5 weeks if production needed
Storage condition4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
BrandArovia
Host speciesEscherichia coli (E.coli)
Fragment TypeTyr525-Glu808
Aliases /SynonymsTAP1, APT1, Peptide transporter involved in antigen processing 1, Really interesting new gene 4 protein, Peptide transporter TAP1, Peptide transporter PSF1, RING4, Antigen peptide transporter 1, PSF-1, ABCB2, Y3, Peptide supply factor 1, PSF1, ATP-binding cassette sub-family B member 2
ReferenceARO-P12869
NoteFor research use only.

Description of Recombinant Human TAP1, N-His

Recombinant Human TAP1: Structure, Activity, and Application

Introduction

Recombinant Human TAP1 (Transporter associated with Antigen Processing 1) is a protein that plays a crucial role in the immune response. It is a member of the ATP-binding cassette (ABC) transporter family and is involved in the transport of peptides from the cytosol into the endoplasmic reticulum (ER) for loading onto major histocompatibility complex (MHC) class I molecules. In this article, we will discuss the structure, activity, and application of Recombinant Human TAP1.

Structure of Recombinant Human TAP1

Recombinant Human TAP1 is a transmembrane protein that consists of 808 amino acids. It has a molecular weight of approximately 90 kDa and is composed of two subunits, TAP1 and TAP2. The TAP1 subunit contains six transmembrane domains (TMDs) and a nucleotide-binding domain (NBD), while the TAP2 subunit contains one TMD and one NBD. These two subunits form a heterodimer that is responsible for the transport of peptides.

Transmembrane Domains

The TMDs of TAP1 are responsible for the translocation of peptides from the cytosol into the ER. These domains are highly conserved and contain hydrophobic amino acids that allow them to span the membrane. The TMDs also contain a signature sequence, known as the Walker A motif, which is involved in ATP binding and hydrolysis.

Nucleotide-Binding Domains

The NBDs of TAP1 are responsible for the binding and hydrolysis of ATP, which provides the energy for peptide transport. These domains also contain the Walker B motif, which is involved in ATP hydrolysis. The NBDs are connected to the TMDs by a linker region, which is crucial for the proper functioning of TAP1.

Activity of Recombinant Human TAP1

The main function of Recombinant Human TAP1 is to transport peptides from the cytosol into the ER for loading onto MHC class I molecules. This process is essential for the presentation of antigens to T cells and the initiation of an immune response. TAP1 achieves this by utilizing the energy from ATP hydrolysis to pump peptides against a concentration gradient from the cytosol into the ER lumen.

In addition to its role in antigen processing, TAP1 also plays a crucial role in the maintenance of cellular homeostasis. It has been shown to transport a wide range of endogenous peptides, including viral peptides, self-peptides, and peptides derived from damaged proteins. This function helps to prevent the accumulation of toxic peptides in the cell and ensures proper immune surveillance.

Application of Recombinant Human TAP1

Recombinant Human TAP1 has a wide range of applications in research, diagnostics, and therapeutics. Its role in antigen processing makes it a valuable tool for studying the immune response and developing vaccines. Recombinant TAP1 can also be used in diagnostic assays to detect the presence of specific peptides, such as viral peptides, in patient samples. In addition, TAP1 has been investigated as a potential therapeutic target for diseases such as cancer and autoimmune disorders.

Furthermore, the production of recombinant TAP1 has allowed for the development of TAP1-deficient cell lines, which can be used to study the effects of TAP1 deficiency on antigen presentation and immune response. These cell lines

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Recombinant Human TAP1, N-His”

Your email address will not be published. Required fields are marked *

Related products

Anti His tag mouse monoclonal antibody
Tag Antibody

Anti His tag mouse monoclonal antibody

PTX17851 214$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products